Abstract
We report two cases of late capsular bag distension syndrome (LCBDS), which is a rare but significant complication following cataract surgery and often presents with blurred vision years after intraocular lens (IOL) implantation. Case 1: An 80-year-old male presented with a one-year history of progressive blurred vision in the right eye. His history included uneventful phacoemulsification and multifocal IOL implantation eight years earlier. Examination revealed dense, turbid fluid behind the IOL. Scheimpflug imaging and anterior segment optical coherence tomography (AS-OCT) detected hyperintense signals between the IOL and posterior capsule. Nd:YAG laser posterior capsulotomy was performed, resulting in complete resolution of the fluid and recovery of 20/20 vision. Case 2: A 60-year-old hypertensive female reported progressive blurred vision in the right eye for nine months. Ten years earlier, she had undergone uncomplicated cataract surgery. AS-OCT and Scheimpflug imaging demonstrated fluid accumulation posterior to the IOL. Nd:YAG capsulotomy led to complete symptom resolution and restoration of 20/20 vision at the one-week follow-up. This report is among the few in the literature to demonstrate how multimodal imaging, particularly AS-OCT and Scheimpflug imaging, can distinctly differentiate late capsular bag distension syndrome from posterior capsule opacification, enabling accurate diagnosis and appropriate management.
Keywords: Capsular distension, multimodal imaging, Nd:YAG laser
Introduction
Late capsular bag distension syndrome (LCBDS) is a rare, late postoperative manifestation of capsular block syndrome characterized by the accumulation of turbid/milky fluid between the intraocular lens (IOL) and posterior capsule. Its frequency after phacoemulsification with in-the-bag IOL implantation has been reported to be around 0.7–1.0% in the literature, highlighting its uncommon nature (1). Presentation may occur months to decades after cataract surgery, with ultra-late cases reported up to 33 years (2). In some cases, biomicroscopic examination alone may not be sufficient for diagnosis, and the condition can be confirmed using various imaging modalities. Nd:YAG posterior capsulotomy is considered first-line therapy and is usually effective, while surgical approaches, such as pars plana vitrectomy, may be required in refractory or complicated cases (1). We report two illustrative cases of LCBDS confirmed with multimodal imaging and outline their diagnostic features and management outcomes.
Case Report 1
An 80-year-old male presented to the ophthalmology outpatient clinic with a gradual decline in vision in his right eye over the span of one year. He had previously undergone uncomplicated cataract surgery, including phacoemulsification and posterior chamber multifocal lens implantation in both eyes, eight years prior, with no reported complications thereafter. At the time of presentation, his corrected distance visual acuity (CDVA) was recorded as hand motion in the right eye and 20/20 in the left eye, with an intraocular pressure (IOP) of 13 mmHg in both eyes. Autorefractor (AR) values were -0.25 (105 -1.75) in the right eye and +1.75 (94 -1.00) in the left eye. Slit-lamp biomicroscopy revealed pseudoexfoliation (PX), and poor pupillary dilation was noted bilaterally. In the right eye, a milky opacity between the lens and the posterior capsule was observed, with no signs of inflammation in the anterior chamber or vitreous (Fig. 1). Despite the difficulty in visualizing the fundus, B-scan ultrasound imaging showed normal findings.
Figure 1.

a) Pre-treatment slit-lamp photograph showing white deposits behind the lens. b) Post-treatment slit-lamp photograph showing complete resolution after Nd:YAG laser capsulotomy.
Multimodal imaging, including Scheimpflug camera imaging (OCULUS Pentacam HR) and anterior segment spectral-domain OCT (AS-OCT) (Optovue RTVue-100, Optovue Inc., Fremont, CA, USA), demonstrated hyperintense signals between the posterior chamber intraocular lens and the posterior capsule. Subsequent Nd:YAG capsulotomy was performed for treatment. Postoperatively, the patient was prescribed topical timolol maleate 0.5% twice daily, topical prednisolone acetate 1.0% ophthalmic solution four times daily, and cyclopentolate HCl 1% drops twice daily to prevent inflammation and elevated intraocular pressure.
On the first postoperative day, CDVA improved to 16/20, IOP was 24 mmHg, +1 anterior chamber cell was noted, the milky fluid had dissipated, and fundus examination was normal. By the first-week follow-up, CDVA had returned to 20/20, IOP was 12 mmHg, and AR readings were +0.25 (110 -2.25). Anterior chamber inflammation had resolved, and AS-OCT and Scheimpflug images confirmed the resolution of milky fluid accumulation (Fig. 2). At subsequent visits, visual acuity remained 20/20, intraocular pressure normalized, and anterior segment and fundus examinations were unremarkable.
Figure 2.

a) Pre-treatment Scheimpflug imaging showing deposits. b) Post-treatment image demonstrating resolution. c) AS-OCT pre-treatment appearance. d) AS-OCT post-treatment appearance.
Case Report 2
A 60-year-old female patient presented to the outpatient clinic with complaints of decreased vision in her right eye for the past nine months. Her medical history revealed uneventful cataract surgery 10 years prior, and the patient had a known diagnosis of hypertension.
Upon examination, CDVA was measured as 12/20 in the right eye and hand motion in the left eye, and IOP was 13/15 mmHg in the right and left eyes, respectively. AR readings were -0.25 (140 -1.00) in the right eye and -5.50 in the left eye. Slit-lamp biomicroscopic examination revealed opacity behind the IOL in the right eye without signs of inflammation in the anterior chamber or vitreous. The red reflex was absent, and a mature cataract was observed in the left eye. Ultrasonography demonstrated normal retinal findings in both eyes. Cataract surgery was planned for the left eye.
In the right eye, AS-OCT and Scheimpflug imaging revealed milky opacification behind the intraocular lens, and an Nd:YAG laser posterior capsulotomy was performed. Following the procedure, the patient was prescribed topical timolol maleate 0.5% twice daily and topical prednisolone acetate 1.0% ophthalmic solution eight times daily. On the first postoperative day, CDVA improved to 20/20, IOP was 12 mmHg, and mild (+1) anterior chamber and vitreous cells were noted. The milky fluid had completely dissipated. At the first-week follow-up, CDVA remained 20/20, IOP was 12 mmHg, and AR values were +0.00 (165 -050). At the three-month follow-up, no complications were observed. We performed phacoemulsification surgery for the left eye one week later.
Discussion
In this report, we presented two cases of LCBDS, detailing their clinical features and treatment approach. Our findings support the existing literature, demonstrating that AS-OCT and Scheimpflug imaging are valuable diagnostic tools when slit-lamp biomicroscopy is insufficient for confirming the diagnosis. Furthermore, we observed that Nd:YAG laser posterior capsulotomy is a safe and effective treatment option for managing late-onset CBDS.
CBDS has been reported after uncomplicated phacoemulsification surgery with continuous curvilinear capsulorhexis (CCC); however, it has rarely been reported with can-opener capsulorhexis (3). Miyake et al. characterized the syndrome according to the time of onset as intraoperative, early postoperative, and late postoperative (4). CBDS develops when the periphery of the capsulorhexis firmly attaches to the anterior surface of the IOL, forming a closed chamber between the intraocular lens and the posterior lens capsule. This leads to the accumulation of cloudy to milky white fluid. While the exact source of this fluid is uncertain, it is believed that metaplastic changes in residual lens epithelial cells result in the production of collagen and other extracellular matrix materials (5). Although CBDS is most commonly observed in eyes with in-the-bag posterior chamber IOLs, a recent report described its occurrence with a sulcus-placed IOL, highlighting that the condition may develop in various lens positions (6). In our case, however, CBDS developed in an eye implanted with a multifocal posterior chamber IOL, a presentation that, to the best of our knowledge, has not been previously documented in the literature. This observation suggests that CBDS may also occur with premium multifocal IOLs, and clinicians should remain alert to this possibility when evaluating postoperative visual decline. CBDS development is associated with various risk factors, such as the retention of ophthalmic viscoelastic devices, insufficient removal of subincisional cortex, juxtaposition of the IOL and capsular bag, postoperative inflammation, and IOL sequestration due to Propionibacterium acnes infection (1,7). Recent studies have reported that cytokines such as interleukin-1, VEGF, IL-8, and VCAM may be effective in CBDS (8,9). Except for the presence of PEX in our first case, no additional risk factors were identified in either patient. Although a recent publication did not list PEX among the established risk factors for CBDS (2), it may indirectly contribute by increasing the likelihood of an uneven or incomplete capsulorhexis, thereby predisposing to this condition.
CBDS may lead to decreased visual acuity and myopic refractive changes. However, this condition can be successfully treated with Nd:YAG laser treatment (9). Symptoms may develop in the early or late postoperative period, and CBDS has been reported up to 20 to 33 years after cataract surgery (2,11). In our cases, symptoms developed 8 and 10 years after cataract surgery, consistent with a late-onset presentation.
While slit-lamp biomicroscopy may raise suspicion, it is often insufficient for confirmation. Various diagnostic modalities have been used to diagnose CBDS, including slit-lamp biomicroscopy, ultrasound biomicroscopy (UBM), AS-OCT, and Scheimpflug-based photography (12-14). In our cases, we employed multimodal imaging with AS-OCT and Scheimpflug multimodal imaging techniques to visualize the fluid and its subsequent disappearance after Nd:YAG laser treatment. These methods are noninvasive, reproducible, and feasible in routine practice. Recently, Jeria et al. demonstrated distinct SS-OCT features of CBDS, suggesting that, with ongoing technological progress, high-resolution multimodal imaging will become increasingly accessible for accurate diagnosis and postoperative monitoring (15).
Nd:YAG laser treatment, encompassing anterior and posterior laser capsulotomy, is widely recommended as the primary approach for addressing late-onset CBDS (16-19). However, potential disadvantages of Nd:YAG laser capsulotomy include elevated IOP, posterior capsule wrinkling, and a high recurrence rate, which present challenges in effective management. Additionally, severe complications such as P. acnes-associated endophthalmitis, dense opaque substance accumulation, and extensive posterior capsule expansion can complicate the procedure, leading some clinicians to prefer surgical intervention (20-22).
Considering factors such as surgical risk, cost considerations, and ease of application, we opted for Nd:YAG laser intervention in our cases. We chose to follow up with the patients at short intervals to monitor for potential increases in intraocular pressure, inflammation, or endophthalmitis. In Case 1, on the first day, there was +1 cell in the anterior chamber, and IOP was 24 mmHg, which quickly regressed with treatment and returned to the normal range. In Case 2, postoperative topical medication was prescribed, and IOP was 12 mmHg on the first postoperative day. Prescribing topical medication after Nd:YAG laser treatment may prevent transient intraocular pressure elevation associated with inflammation. In case presentations of CBDS, the most feared complication of treatment is the possibility of undetected Propionibacterium acnes and the subsequent development of endophthalmitis. We were unable to obtain a sample from the anterior chamber and were therefore unable to demonstrate the absence of Propionibacterium acnes. In cases with high suspicion, to minimize the possibility of Nd:YAG laser-induced Propionibacterium dissemination and endophthalmitis, 25-gauge pars plana vitrectomy with posterior capsulotomy may be considered (21). Our decision to perform Nd:YAG capsulotomy in these cases was based on the absence of anterior chamber or vitreous inflammation indicative of Propionibacterium infection. This decision was further supported by current evidence indicating that this treatment option is safe, effective, and appropriate, without the associated risks of a more invasive pars plana approach. Throughout the follow-up period, our patients did not experience severe complications such as uncontrollable IOP elevation, uveitis, endophthalmitis, cystoid macular edema, or retinal detachment.
Conclusion
Our study highlights the diagnosis of LCBDS as a rare cause of decreased vision occurring long after uneventful cataract surgery. Only a limited number of such cases have been reported in the literature, underscoring the rarity of this condition. When slit-lamp biomicroscopy does not provide a clear diagnosis, multimodal anterior segment imaging, including AS-OCT and Scheimpflug photography, serves as a valuable adjunct for confirming the presence and extent of intracapsular fluid accumulation. Although Nd:YAG laser posterior capsulotomy generally yields favorable outcomes, this intervention should be performed only in the absence of clinical suspicion for Propionibacterium acnes infection.
Footnotes
How to cite this article: Dogan Gokce G, Ozkan G, Akkaya Turhan S. Assessing Multi-Modal Imaging for Late Capsular Bag Distension Syndrome: A Study of Two Clinical Cases. Beyoglu Eye J 2026; 11(2): 176-180.
Disclosures
Ethics Committee Approval
These are case reports, therefore ethics committee approval was not required in accordance with institutional policies.
Informed Consent
Written informed consents were obtained from both patients.
Peer-review
Externally peer-reviewed.
Authorship Contributions
Concept: S.A.T., G.D.G.; Design: S.A.T., G.D.G.; Supervision: S.A.T.; Resource: G.O., G.D.G.; Materials: G.O., G.D.G.; Data Collection and/or Processing: G.O.; Analysis and/or Interpretation: S.A.T., G.D.G. ; Literature Search: G.O., G.D.G., S.A.T.; Writing: G.D.G., S.A.T.; Critical Reviews: S.A.T.
Conflict of Interest
None declared.
Use of AI for Writing Assistance
The authors declared that artificial intelligence was not used in the study.
Financial Disclosure
The authors declared that this study received no financial support.
References
- 1.Kanclerz P, Wang X. Postoperative Capsular Bag Distension Syndrome-Risk Factors and Treatment. Semin Ophthalmol. 2019;34(6):409–19. doi: 10.1080/08820538.2019.1640750. [DOI] [PubMed] [Google Scholar]
- 2.Sunil D, Shalini S. Capsular bag distension syndrome. Delhi Journal of Ophthalmology. 2024;34:88–94. [Google Scholar]
- 3.Miyake K, Ota I, Miyake S, Horiguchi M. Liquefied aftercataract: a complication of continuous curvilinear capsulorhexis and intraocular lens implantation in the lens capsule. Am J Ophthalmol. 1998;125:429–35. doi: 10.1016/s0002-9394(99)80182-2. [DOI] [PubMed] [Google Scholar]
- 4.Miyake K, Ota I, Ichihashi S, Miyake S, Tanaka Y, Terasaki H. New classification of capsular block syndrome. J Cataract Refract Surg. 1998;24:1230–4. doi: 10.1016/s0886-3350(98)80017-5. [DOI] [PubMed] [Google Scholar]
- 5.Eifrig DE. Capsulorhexis-related lacteocrumenasia. J Cataract Refract Surg. 1997;23:450–4. doi: 10.1016/s0886-3350(97)80193-9. [DOI] [PubMed] [Google Scholar]
- 6.Singh M, Potti S. Capsular bag distension syndrome with sulcus IOL acting as a seal. Indian Journal of Ophthalmology-Case Reports. 2024;4:719–21. [Google Scholar]
- 7.Mastropasqua L, Toto L, De Nicola G, Nubile M, Carpineto P. OCT imaging of capsular block syndrome with crystalline cortical remnants in the capsular bag. Ophthalmic Surg Lasers Imaging. 2009;40:399–402. doi: 10.3928/15428877-20096030-08. [DOI] [PubMed] [Google Scholar]
- 8.Du YH, Liang XF, Hirooka K, Xia HK, Jia ZY. A potential role for inflammatory cytokines in a rare late-onset capsular block syndrome: a case report. BMC Ophthalmol. 2024;24:53. doi: 10.1186/s12886-024-03320-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Huang Y, Ye Z, Li H, Li Z. Outcome of Surgical Treatment in Late-Onset Capsular Block Syndrome. J Ophthalmol. 2017;2017:1847179. doi: 10.1155/2017/1847179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Yang MK, Wee WR, Kwon JW, Han YK. Anterior chamber depth and refractive change in late postoperative capsular bag distension syndrome: a retrospective analysis. PLoS One. 2015;10:e0125895. doi: 10.1371/journal.pone.0125895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Plemel DJA, Benson MD, Rayat JS, Greve MDJ, Tennant MTS. Capsular block syndrome 20 years post-cataract surgery. Can J Ophthalmol. 2018;53:e222–4. doi: 10.1016/j.jcjo.2018.02.009. [DOI] [PubMed] [Google Scholar]
- 12.Zhu XJ, Zhang KK, Yang J, Ye HF, Lu Y. Scheimpflug imaging of ultra-late postoperative capsular block syndrome. Eye (Lond) 2014;28:900–4. doi: 10.1038/eye.2014.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Das K. Delayed capsular bag distension syndrome. Oman J Ophthalmol. 2010;3:155–6. doi: 10.4103/0974-620X.71905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Gupta K, Bhattacharjee H, Deshmukh S. Scheimpflugimaging in the late postoperative capsular bag distension syndrome. TNOA Journal of Ophthalmic Science and Research. 2019;57:332–3. [Google Scholar]
- 15.Jeria S, Nagar R, Nangia P, Nangia V. Capsular bag distension syndrome: Swept-source optical coherence tomography features. Oman J Ophthalmol. 2025;18:93–4. doi: 10.4103/ojo.ojo_192_24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Pinsard L, Rougier MB, Colin J. Neodymium:YAG laser treatment of late capsular block syndrome. J Cataract Refract Surg. 2011;37:2079–80. doi: 10.1016/j.jcrs.2011.09.012. [DOI] [PubMed] [Google Scholar]
- 17.Grover DS, Goldberg RA, Ayres B, Fantes F. Treatment of late-onset capsular distension syndrome with a neodymium: YAG laser peripheral iridotomy and anterior capsulotomy. J Cataract Refract Surg. 2012;38:938–40. doi: 10.1016/j.jcrs.2012.04.003. [DOI] [PubMed] [Google Scholar]
- 18.Vlasenko AV, Kopayev SY, Verzin AA, Timokhov VL, Uzunyan DG, Shormaz IN. Sindrom kapsul’nogo bloka posle fakoémul’sifikatsii katarakty [Late capsular block syndrome] Vestn Oftalmol. 2019;135:86–97. doi: 10.17116/oftalma201913504186. [Article in Russian] [DOI] [PubMed] [Google Scholar]
- 19.Gobeka HH, Gülyeşil FF, Sabaner MC. Acute effects of neodymium-doped yttrium aluminum garnet laser capsulotomy on anterior segment parameters in capsular bag distension syndrome. Photobiomodul Photomed Laser Surg. 2023;41:429–34. doi: 10.1089/photob.2022.0151. [DOI] [PubMed] [Google Scholar]
- 20.Almousa KS, Refka MN. Late-onset capsular bag distention syndrome resistant to laser treatment: a case report. J Surg Case Rep. 2021;2021:rjab278. doi: 10.1093/jscr/rjab278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Galvin JC, Berdoukas P, Fung AT. Two cases of very late-onset capsular bag distension syndrome. Am J Ophthalmol Case Rep. 2018;10:268–70. doi: 10.1016/j.ajoc.2018.03.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Al-Mulla AH, Al-Rushoud MW. Unusual late presentation of capsular bag distension syndrome associated with propionibacterium acnes endophthalmitis. Cureus. 2021;13:e19684. doi: 10.7759/cureus.19684. [DOI] [PMC free article] [PubMed] [Google Scholar]
